Why Do Patients Develop Anemia With Chronic Inflammation?

Annals On Call Podcast
21/07/2020 20 min

Listen "Why Do Patients Develop Anemia With Chronic Inflammation?"

Descargar episodio Ver en sitio original

Episode Synopsis

Dr. Centor discusses inflammation-associated anemia and its response to interluekin-1ß inhibition with canakinumab in CANTOS (Canakinumab Anti-inflammatory Thrombosis Outcomes Study) with trial investigator Dr. Mounica Vallurupalli.

More episodes of the podcast Annals On Call Podcast

Complications Associated With Transvenous Cardiac Implantable Devices 15/12/2025
Cost-Effectiveness of Weight Loss Drugs for Knee Osteoarthritis 01/12/2025
Palliative Care: A Family Perspective 17/11/2025
What You May Have Missed in 2024: Part 3 03/11/2025
What You May Have Missed in 2024 - Part 2 20/10/2025
High-Concentration Cannabinoids: Are They Safe? 06/10/2025
What You May Have Missed in 2024: Part 1 15/09/2025
Fibrillation - When Ablation is the Way to Go 01/09/2025
Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes 18/08/2025
Comparison of Dose Escalation Versus Switching to Tirzepatide When Diabetes Control is Inadequate on Dulaglutide 04/08/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA